Get the Stockscreener App
98.92
0.65%
0.64
After Hours:
98.79
-0.13
-0.13%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $98.92, with a volume of 8.28M.
It is up +0.65% in the last 24 hours and up +0.56% over the past month.
See More
Previous Close:
$98.28
Open:
$99.41
24h Volume:
8.28M
Relative Volume:
0.79
Market Cap:
$251.88B
Revenue:
$63.17B
Net Income/Loss:
$12.15B
P/E Ratio:
20.74
EPS:
4.77
Net Cash Flow:
$14.84B
1W Performance:
+2.37%
1M Performance:
+0.56%
6M Performance:
-14.17%
1Y Performance:
-18.69%
1-Day Range:
$98.23
$99.41
1-Week Range:
$95.41
$99.41
52-Week Range:
$94.48
$134.63
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
98.92 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
|
LLY
Lilly Eli Co
|
823.23 | 778.66B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
85.34 | 379.90B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
152.87 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
ABBV
Abbvie Inc
|
175.59 | 310.55B | 55.53B | 5.12B | 15.62B | 2.88 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things - Insider Monkey
Noteworthy Insider Activity: Chirfi Guindo Invests $2.76M In Merck & Co Stock - Benzinga
Chairman Of Merck & Co Makes $9.33M Buy - Benzinga
EVP & CFO Of Merck & Co Makes $2.29M Buy - Benzinga
Johannes Oosthuizen's Recent Buy: Acquires $848K In Merck & Co Stock - Benzinga
Major Purchase Alert: Jennifer Zachary Invests $2.49M In Merck & Co Stock - Benzinga
Crews Bank & Trust Invests $900,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock? - The Motley Fool
OLD National Bancorp IN Sells 3,371 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Shares Sold by BDF Gestion - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Sentry LLC - MarketBeat
Merck: Phase III study on Winrevair halted -January 30, 2025 at 08:16 am EST - Marketscreener.com
Merck & Co., Inc. (NYSE:MRK) Stock Position Raised by Synergy Asset Management LLC - MarketBeat
Merck Stops Late-Stage Trial of Winrevair Early, Moves to Final Analysis -January 30, 2025 at 07:57 am EST - Marketscreener.com
Highland Capital Management LLC Has $30.26 Million Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Summa Corp. Invests $506,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Manning & Napier Advisors LLC Invests $7.42 Million in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck to stop lung condition drug study early due to strong efficacy data - Reuters
Merck's SWOT analysis: pharma giant's stock faces China setback, PAH potential - MSN
Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Stocks to Buy Under $100? - Insider Monkey
A Closer Look at Merck & Co's Options Market Dynamics - Benzinga
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Orrstown Financial Services Inc. - MarketBeat
Swedbank AB Purchases 130,541 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Strategic Blueprint LLC - MarketBeat
Asset Dedication LLC Sells 15,418 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Robeco Institutional Asset Management B.V. Trims Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Sumitomo Life Insurance Co. Reduces Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Twelve Points Wealth Management LLC Increases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc.'s (NYSE:MRK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Merck & Co., Inc. (MRK): Is This Healthcare Stock A Good Buy? - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Shares Sold by SteelPeak Wealth LLC - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Capital Investment Counsel LLC - MarketBeat
Orca Wealth Management LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Nilsine Partners LLC Has $1.19 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Hodgkin Lymphoma Market Promising Growth Anticipated by 2031 | Merck & Co., Inc., Bristol Myers Squibb, Seagen Inc. - openPR
Share Buyback Program Announced by Merck & Co., Inc. (NYSE:MRK) Board of Directors - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Plans $0.81 Quarterly Dividend - MarketBeat
Merck announces $0.81 dividend and $10 billion buyback - MSN
Merck Announces $10 Billion Share Repurchase Authorization -January 28, 2025 at 02:01 pm EST - Marketscreener.com
Merck's Board Authorizes Additional $10 Billion Stock Buyback Plan -January 28, 2025 at 01:39 pm EST - Marketscreener.com
Merck Authorizes $10 Billion Share Repurchase, Maintains Quarterly Dividend at $0.81 a Share - Marketscreener.com
Merck stock in focus after share buybacks (MRK:NYSE) - Seeking Alpha
Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization - Business Wire
Is Merck & Co. (MRK) Among Kevin O’Leary’s Stock Picks for 2025? - Yahoo Finance
Perigon Wealth Management LLC Sells 4,971 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Griffin Asset Management Inc. Sells 2,868 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Sterling Investment Counsel LLC Trims Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Forecasting The Future: 12 Analyst Projections For Merck & Co - Benzinga
Merck & Co., Inc. (NYSE:MRK) is Town & Country Bank & Trust CO dba First Bankers Trust CO's 7th Largest Position - MarketBeat
Buffington Mohr McNeal Decreases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):